Date | Price Target | Rating | Analyst |
---|---|---|---|
7/25/2024 | $34.00 → $35.00 | Outperform → Neutral | Mizuho |
3/22/2024 | $32.00 → $35.00 | Neutral → Buy | Citigroup |
2/26/2024 | $31.00 → $35.00 | Equal Weight → Overweight | Wells Fargo |
2/8/2024 | $30.00 | Underperform → Neutral | Exane BNP Paribas |
1/30/2024 | $36.00 | Buy | Deutsche Bank |
1/16/2024 | $33.00 → $31.00 | Buy → Neutral | BofA Securities |
11/6/2023 | Neutral → Underperform | Exane BNP Paribas | |
10/11/2023 | $36.00 | Neutral | Exane BNP Paribas |
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
NEW YORK, March 10, 2021 /PRNewswire/ -- Maplewood Senior Living and Omega Healthcare Investors, Inc. (NYSE: OHI) today announced the official opening of Inspīr Carnegie Hill, the new luxury senior living community on Manhattan's Upper East Side. Inspīr Carnegie Hill is a next-generation concept for urban senior living on a luxury level, offering residents a transformative, one-of-a-kind experience made possible by combining expertise and insights from the residential, hospitality and healthcare industries. Featuring state-of-the-art spaces, exceptional care, intelligent technology and immersive experiences, Inspīr Carnegie Hill has curated an environment and lifestyle that supports a philos
Mizuho downgraded Omega Health from Outperform to Neutral and set a new price target of $35.00 from $34.00 previously
Citigroup upgraded Omega Health from Neutral to Buy and set a new price target of $35.00 from $32.00 previously
Wells Fargo upgraded Omega Health from Equal Weight to Overweight and set a new price target of $35.00 from $31.00 previously
Completed $648 Million in New Investments Year-to-Date Increased Full Year Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended June 30, 2024. SECOND QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $117 million, or $0.45 per common share, compared to $62 million, or $0.25 per common share, for Q2 2023. Nareit Funds From Operations ("Nareit FFO") for the quarter of $189 million, or $0.72 per common share, on 262 million weighted-average common shares outstanding, compared to $155 million, or $0.63 per common share, on 246 million weighted-average common shares outstanding, f
Omega Healthcare Investors, Inc. (NYSE:OHI) today announced the quarterly dividend on its common stock and its second quarter earnings release date. Quarterly Dividend Declaration Omega today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Thursday, August 15, 2024, to common stockholders of record as of the close of business on Monday, August 5, 2024. Second Quarter Earnings Release and Conference Call Omega also announced today that it is scheduled to release its earnings results for the quarter ended June 30, 2024, on Thursday, August 1, 2024, after market close. In conjunction with its relea
Completed $240 Million in New Investments Year-to-Date Repaid a $400 Million Debt Maturity in April Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended March 31, 2024. FIRST QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $69 million, or $0.27 per common share, compared to $37 million, or $0.15 per common share, for Q1 2023. Nareit Funds From Operations ("Nareit FFO") for the quarter of $153 million, or $0.60 per common share, on 257 million weighted-average common shares outstanding, compared to $146 million, or $0.60 per common share, on 243 million weighted-average common shares outstanding,
Completed $648 Million in New Investments Year-to-Date Increased Full Year Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended June 30, 2024. SECOND QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $117 million, or $0.45 per common share, compared to $62 million, or $0.25 per common share, for Q2 2023. Nareit Funds From Operations ("Nareit FFO") for the quarter of $189 million, or $0.72 per common share, on 262 million weighted-average common shares outstanding, compared to $155 million, or $0.63 per common share, on 246 million weighted-average common shares outstanding, f
Omega Healthcare Investors, Inc. (NYSE:OHI) today announced the quarterly dividend on its common stock and its second quarter earnings release date. Quarterly Dividend Declaration Omega today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Thursday, August 15, 2024, to common stockholders of record as of the close of business on Monday, August 5, 2024. Second Quarter Earnings Release and Conference Call Omega also announced today that it is scheduled to release its earnings results for the quarter ended June 30, 2024, on Thursday, August 1, 2024, after market close. In conjunction with its relea
Omega Healthcare Investors, Inc. (the "Company" or "Omega") (NYSE:OHI) today issued the following statement in response to LaVie Care Centers' ("LaVie") announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Georgia. Omega believes this filing is a necessary and important step in creating an entity that is operationally solvent and sustainable, with enhanced liquidity and a strengthened balance sheet. During this filing, our focus, like LaVie's, is on maintaining quality of care for the residents of these facilities, on supporting the employees that devote their careers to delivering this care, and on the key vendors that help provide operational
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector. Brandywine Realty Trust (NYSE:BDN) Dividend Yield: 12.77% Truist Securities analyst Michael Lewis maintained a Buy rating and cu
Scotiabank analyst Nicholas Yulico maintains Omega Healthcare Invts (NYSE:OHI) with a Sector Perform and raises the price target from $32 to $33.
Truist Securities analyst Michael Lewis maintains Omega Healthcare Invts (NYSE:OHI) with a Hold and raises the price target from $32 to $33.
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
10-Q - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)